BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 26631238)

  • 1. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.
    Maina T; Bergsma H; Kulkarni HR; Mueller D; Charalambidis D; Krenning EP; Nock BA; de Jong M; Baum RP
    Eur J Nucl Med Mol Imaging; 2016 May; 43(5):964-973. PubMed ID: 26631238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
    Nock BA; Kaloudi A; Lymperis E; Giarika A; Kulkarni HR; Klette I; Singh A; Krenning EP; de Jong M; Maina T; Baum RP
    J Nucl Med; 2017 Jan; 58(1):75-80. PubMed ID: 27493272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin.
    Lymperis E; Kaloudi A; Sallegger W; Bakker IL; Krenning EP; de Jong M; Maina T; Nock BA
    Bioconjug Chem; 2018 May; 29(5):1774-1784. PubMed ID: 29664606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga/177Lu-NeoBOMB1, a Novel Radiolabeled GRPR Antagonist for Theranostic Use in Oncology.
    Dalm SU; Bakker IL; de Blois E; Doeswijk GN; Konijnenberg MW; Orlandi F; Barbato D; Tedesco M; Maina T; Nock BA; de Jong M
    J Nucl Med; 2017 Feb; 58(2):293-299. PubMed ID: 27609789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts.
    Schroeder RP; van Weerden WM; Krenning EP; Bangma CH; Berndsen S; Grievink-de Ligt CH; Groen HC; Reneman S; de Blois E; Breeman WA; de Jong M
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1257-66. PubMed ID: 21431398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Stabilized SB3, an Attractive GRPR Antagonist, for Pre- and Intra-Operative Imaging for Prostate Cancer.
    Bakker IL; van Tiel ST; Haeck J; Doeswijk GN; de Blois E; Segbers M; Maina T; Nock BA; de Jong M; Dalm SU
    Mol Imaging Biol; 2018 Dec; 20(6):973-983. PubMed ID: 29556947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [
    Kanellopoulos P; Lymperis E; Kaloudi A; de Jong M; Krenning EP; Nock BA; Maina T
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32731473
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD.
    Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X
    J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative PET imaging study of
    Ferguson S; Wuest M; Richter S; Bergman C; Dufour J; Krys D; Simone J; Jans HS; Riauka T; Wuest F
    Nucl Med Biol; 2020; 90-91():74-83. PubMed ID: 33189947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microPET and autoradiographic imaging of GRP receptor expression with 64Cu-DOTA-[Lys3]bombesin in human prostate adenocarcinoma xenografts.
    Chen X; Park R; Hou Y; Tohme M; Shahinian AH; Bading JR; Conti PS
    J Nucl Med; 2004 Aug; 45(8):1390-7. PubMed ID: 15299066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Gastrin Releasing Peptide Receptor-Directed [
    Nock BA; Charalambidis D; Sallegger W; Waser B; Mansi R; Nicolas GP; Ketani E; Nikolopoulou A; Fani M; Reubi JC; Maina T
    J Med Chem; 2018 Apr; 61(7):3138-3150. PubMed ID: 29517903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRPr Antagonist
    Bakker IL; Fröberg AC; Busstra MB; Verzijlbergen JF; Konijnenberg M; van Leenders GJLH; Schoots IG; de Blois E; van Weerden WM; Dalm SU; Maina T; Nock BA; de Jong M
    J Nucl Med; 2021 Nov; 62(11):1517-1523. PubMed ID: 33789933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiometal Complexes as Pharmacokinetic Modifiers: A Potent
    Schreck MV; Burgard C; Schmidtke A; Hierlmeier I; Stemler T; Maus S; Rosar F; Jung M; Speicher A; Ezziddin S; Holland JP; Bartholomä MD
    Mol Pharm; 2023 Dec; 20(12):6463-6473. PubMed ID: 37978936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 64Cu-NO2A-RGD-Glu-6-Ahx-BBN(7-14)NH2: a heterodimeric targeting vector for positron emission tomography imaging of prostate cancer.
    Jackson AB; Nanda PK; Rold TL; Sieckman GL; Szczodroski AF; Hoffman TJ; Chen X; Smith CJ
    Nucl Med Biol; 2012 Apr; 39(3):377-87. PubMed ID: 22226021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET Using a GRPR Antagonist
    Zhang J; Niu G; Fan X; Lang L; Hou G; Chen L; Wu H; Zhu Z; Li F; Chen X
    J Nucl Med; 2018 Jun; 59(6):922-928. PubMed ID: 29123014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation.
    Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA
    J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.